ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
3,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,6,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
3,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3,8,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
3,9,Myopic chorioretinal degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
3,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3,11,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3,12,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3,13,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
4,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
4,3,Lacrimal disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
4,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
4,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
6,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
6,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
7,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
7,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
8,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
8,3,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
9,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
9,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
